Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies

Cell therapies and other biologics depend on ultracold storage and tightly controlled shipping. ARPA-H has funded teams of companies, research agencies, and universities developing alternatives, aiming to widen patient access to these therapies. The post ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies appeared first on GEN - Genetic Engineering and…

We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.

Read the original at genengnews.com →

More in Health & Medicine

More from Thursday 8 October →